UNLIMITED TURBO SHORT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000PC0MH63

Market Closed - Deutsche Boerse AG 12:50:22 26/06/2024 am IST
1.38 EUR +2.22% Intraday chart for UNLIMITED TURBO SHORT - FRESENIUS MEDICAL CARE
Current month+32.69%
1 month+30.19%
Date Price Change
25/24/25 1.38 +2.22%
24/24/24 1.35 -2.88%
21/24/21 1.39 +6.11%
20/24/20 1.31 -2.24%
19/24/19 1.34 +3.88%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 12:50 am IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC0MH6
ISINDE000PC0MH63
Date issued 31/03/2023
Strike 49.47
Maturity Unlimited
Parity 10 : 1
Emission price 1.44
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.02
Lowest since issue 0.16

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.67 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.07%
Consensus